SCHEMBL15823243

SCHEMBL15823243

CC(C)C(O)(Cn1cncn1)c1cc(Oc2ccc(Cl)cc2)ccc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 11/20 0.44
ALDH1A1 P00352 3/20 0.44
KMT2A Q03164 2/20 0.43
CYP2C9 P11712 9/20 0.41
CYP2C19 P33261 9/20 0.41
CYP1A2 P05177 6/20 0.41
CYP2D6 P10635 6/20 0.41
KCNH2 Q12809 2/20 0.41
LMNA P02545 2/20 0.39
CYP2B6 P20813 1/20 0.39
CYP3A5 P20815 1/20 0.39
CYP3A7 P24462 1/20 0.39
MAPK1 P28482 1/20 0.39
CYP3A43 Q9HB55 1/20 0.39
CYP46A1 Q9Y6A2 1/20 0.39
MEN1 O00255 1/20 0.39
HSP90AA1 P07900 3/20 0.37
POLB P06746 1/20 0.37
CYP19A1 P11511 2/20 0.37
CYP11B1 P15538 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15824336 0.92 CYP3A4 (0.44) CYP3A4ALDH1A1KMT2ACYP2C9CYP2C19
SCHEMBL29488437 0.92 CYP3A4 (0.44) CYP3A4ALDH1A1KMT2ACYP2C9CYP2C19
SCHEMBL15823475 0.92 CYP3A4 (0.44) CYP3A4ALDH1A1KMT2ACYP2C9CYP2C19
SCHEMBL14698117 0.92 CYP3A4 (0.44) CYP3A4ALDH1A1KMT2ACYP2C9CYP2C19
SCHEMBL29427680 0.91 CYP3A4 (0.43) CYP3A4ALDH1A1KMT2ACYP2C9CYP2C19
SCHEMBL19615889 0.91 CYP3A4 (0.43) CYP3A4ALDH1A1KMT2ACYP2C9CYP2C19
SCHEMBL15822678 0.89 CYP3A4 (0.43) CYP3A4ALDH1A1KMT2ACYP2C9CYP2C19
SCHEMBL14645415 0.89 CYP3A4 (0.43) CYP3A4ALDH1A1KMT2ACYP2C9CYP2C19
SCHEMBL29359755 0.89 CYP3A4 (0.43) CYP3A4ALDH1A1KMT2ACYP2C9CYP2C19
SCHEMBL29430293 0.89 CYP3A4 (0.43) CYP3A4ALDH1A1KMT2ACYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150329501-A1 SUBSTITUTED [1,2,4]TRIAZOLE COMPOUNDS AND THEIR USE AS FUNGICIDES BASF SE (DE) 2015-11-19 US disclosed
EP-2935237-A1 SUBSTITUTED [1,2,4]TRIAZOLE COMPOUNDS AND THEIR USE AS FUNGICIDES BASF SE (DE) 2015-10-28 EP disclosed
WO-2014095672-A1 SUBSTITUTED [1,2,4]TRIAZOLE COMPOUNDS AND THEIR USE AS FUNGICIDES BASF SE (DE) 2014-06-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150329501-A1 SUBSTITUTED [1,2,4]TRIAZOLE COMPOUNDS AND THEIR USE AS FUNGICIDES CYP51A1, CYP4B1, CYP1B1 CYP3A4 4/4885ALDH1A1 228/4885KMT2A 1466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.